NCT01045109View on ClinicalTrials.gov

Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen.

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

cholecalciferol

4,000 I.U. softgel daily orally for 48 weeks

DIETARY_SUPPLEMENT

cholecalciferol

cholecalciferol or vitamin D3 4,000 IU daily for 48 weeks

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT01045109 - Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen. | Biotech Hunter | Biotech Hunter